Christine Pellizzari - 15 Jun 2023 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Director
Signature
/s/ Stephen Brady, Attorney-in-Fact for Christine Pellizzari
Issuer symbol
TPST
Transactions as of
15 Jun 2023
Transactions value $
$0
Form type
4
Date filed
20 Jun 2023, 16:48
Previous filing
22 May 2023
Next filing
15 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (right to buy) Award $0 +8.2K $0.00 8.2K 15 Jun 2023 Common Stock 8.2K $1.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option will vest in full on the earlier of (i) June 15, 2024, or (ii) the day of the Issuer's 2024 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date.